Primary prevention
Your Organisational Guidance
ebpracticenet urges you to prioritise the following organisational guidance:
Kleincellige en niet-kleincellige longkanker: diagnose, behandeling en opvolgingPublished by: KCELast published: 2013Cancer du poumon à petites cellules et non à petites cellules : diagnostic, traitement et suiviPublished by: KCELast published: 2013Smoking cessation
Patients should be asked about current smoking status (including e-cigarettes and vaping products) on each presentation to medical care. Smokers should be educated about the health risks of smoking and advised to quit. Multiple options (non-pharmacological and pharmacological) are available to assist patients with smoking cessation.[51]
The US Preventive Services Task Force (USPSTF) recommends smokers be directed to approved pharmacotherapy for smoking cessation. The USPSTF found insufficient evidence on the use of e-cigarettes for tobacco smoking cessation in adults and concluded that the balance of benefits and harms cannot be determined.[52]
Vitamin supplements
One systematic review and meta-analysis of randomised controlled trials found no beneficial effect of vitamin supplements for the prevention of lung cancer and lung cancer mortality.[53]
[ 
]
[ ]
The US Preventive Services Task Force recommends against the use of beta carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer, as well as concluding that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamin supplements for the prevention of cardiovascular disease or cancer.[54]
Secondary prevention
Use of this content is subject to our disclaimer